Navigating My Myeloma Journey: Insights and Advice on CAR-T Therapy

Panelists discuss advice for patients with myeloma considering chimeric antigen receptor T-cell therapy, drawing from their experiences to guide patients through the decision-making process and expectations for the treatment journey.

EP: 1.Navigating the Myeloma Journey: Insights from Diagnosis to First-Line Treatment in Standard-Risk Patient

EP: 2.Exploring CAR-T Therapy: Discussing Its Introduction and Shared Decision-Making in Myeloma Treatment

EP: 3.CAR-T Therapy in Standard-Risk Multiple Myeloma: Rationale and Patient Preparation

EP: 4.CAR-T Therapy Journey: From Cell Collection to Managing Challenges

EP: 5.Preparing for CAR-T Therapy: Key Considerations and Timing in Multiple Myeloma Treatment

EP: 6.Managing CAR-T Therapy: Side Effect Monitoring and Collaborative Patient Care

EP: 7.Navigating Recovery: CAR-T Cell Therapy Experience

EP: 8.Navigating the Long-Term Landscape: CAR-T Therapy Patient Monitoring and Care

Now Viewing

EP: 9.Navigating My Myeloma Journey: Insights and Advice on CAR-T Therapy

EP: 10.The Future of CAR-T: Advancing Myeloma Treatment Strategies

Video content above is prompted by the following:

Based on your experience, what advice would you give to other patients with myeloma who are considering chimeric antigen receptor T-cell therapy?

Recent Videos